Assessment of Response to Dopamine Agonist (Pramipexole) in the treatment of Migraine Patients with Restless Legs Syndrome

[1]  A. Sayad,et al.  The role of blood pressures in patients with a headache , 2016 .

[2]  Y. Cho,et al.  Response to the letter "Characterization of the painful restless legs syndrome". , 2015, Sleep medicine.

[3]  S. Sacco,et al.  O032. Associations between any headache and obesity: results from a systematic review and meta-analysis of observational studies , 2015, The Journal of Headache and Pain.

[4]  M. Chu,et al.  Migraine and restless legs syndrome are associated in adults under age fifty but not in adults over fifty: a population-based study , 2015, The Journal of Headache and Pain.

[5]  T. Jensen,et al.  Prolactinoma-associated headache and dopamine agonist treatment , 2014, Cephalalgia : an international journal of headache.

[6]  R. Allen,et al.  Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome. , 2014, Sleep.

[7]  J. Winkelman,et al.  Comparison of pregabalin with pramipexole for restless legs syndrome. , 2014, The New England journal of medicine.

[8]  M. Buchfuhrer.  Strategies for the Treatment of Restless Legs Syndrome , 2012, Neurotherapeutics.

[9]  M. Marmura.  Use of Dopamine Antagonists in Treatment of Migraine , 2012, Current Treatment Options in Neurology.

[10]  H. Fernandez,et al.  Updates in the medical management of Parkinson disease , 2012, Cleveland Clinic Journal of Medicine.

[11]  P. Goadsby,et al.  Dopamine: what's new in migraine? , 2010, Current opinion in neurology.

[12]  A. Belfiore,et al.  Relationship between high prolactine levels and migraine attacks in patients with microprolactinoma , 2008, The Journal of Headache and Pain.

[13]  P. Goadsby,et al.  Dopamine inhibits trigeminovascular transmission in the rat , 2007, Annals of neurology.

[14]  R. Allen.  Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). , 2004, Sleep medicine.

[15]  John Seibyl,et al.  Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. , 2004, Archives of neurology.

[16]  S. Leurgans,et al.  Dopaminergic Hypersensitivity In Patients With Parkinson Disease And Migraine , 2004, Clinical neuropharmacology.